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Problem Identification
• During my rotation at South Burlington Family Practice (SBFP), I had multiple encounters 
with adult male patient across all ages who asked about testosterone. They were more 
likely to connect their symptoms with low T before other potential causes. Complaints 
included:
• “I feel like my sex life isn’t the same.”
• “I feel more tired lately.”
• Recently, there has been an increase in commercials and ads by pharmaceuticals pushing 
for testosterone supplementation by capitalizing on the sensitive subject of “low T” or 
decreased manhood and vague non-specific symptoms of low T.
• The idea that testosterone is something that occurs within our natural body and that we 
are only supplementing what’s originally there can be misleading. Many may interpret 
this as there is no harm but good, but the latest studies have shown otherwise. 
• It is clear that there is a lack of proper understanding regarding testosterone treatment 
in the public, from when treatment would be suitable to what the risks and benefits are.
Public Health Cost
• Rates of testosterone therapy prescription have increased markedly in 
the United States over the past decade. Annual prescriptions for 
testosterone increased by more than 5-fold from 2000 to 2011, 
reaching 5.3 million prescriptions and a market of $1.6 billion in 2011.
• Multiple research studies have shown that the use of testosterone 
therapy is associated with increased risk of mortality, myocardial 
infarction, or ischemic stroke.
• Heart disease and stroke are currently the leading and fifth leading 
cause of death in men, respectively.
Community Perspective on 
Issue and Support for Project
• “My biggest concern is that the public is receiving their knowledge from TV 
and advertisements, and they come in with a biased opinion expecting 
something…educating people on the risks and benefits would be helpful.” –
Dr. [Name Withheld]
• “There is unclear benefit with treatment of exogenous testosterone. Yet 
clearly established adverse side effects.... Low T has very vague nonspecific 
symptoms with billion dollar direct marketing by pharmaceuticals. It would 
be helpful to have public education…” –Dr. [Name Withheld]
• “There is little evidence that it [testosterone supplements] helps symptoms 
and it’s marketed heavily. Everyone in their 50s is not going to feel like their 
20s. The ad is looking for anyone who is a little tired, and asking to get your 
T checked… it is important to help people understand the risk and 
benefits.” – Dr. [Name Withheld]
Intervention 
and Methodology
• Create an easy to understand educational handout for the general 
public.
• The handout will focus on the basic definition of late onset 
hypogonadism (LOH) and include a breakdown of risks and benefits.
• Display the handout at the waiting room of SBFP and other clinics for 
interested patients to browse.
• Crate a .dotphrase in PRISM so providers can print out the 
information out for patient education when patients inquire about 
low T.
Results
• Discussed with multiple healthcare providers on key points to include in 
the handout.
• Educational handout was sent to healthcare providers for review and 
revised accordingly. 
• Discussed with office manager of SBFP the feasibility of displaying 
education material or best way to have the material distributed for the 
public.
• Public display may not be an option. Was told that the best way for distribution 
would be to integrate it into PRISM for doctor’s to print out and give to patients.
• Currently working to implement .dotphrase and making providers aware to 
increase provider usage.
Evaluation of Effectiveness 
and Limitations
• Evaluation
• Survey providers whether they feel patient who received the information 
handout after inquiring about testosterone at a visit had an improved 
understanding of the risk and benefits of its use at the follow-up visit.
• Limitations
• Material is distributed passively upon inquiry rather than actively promoted, 
which limits the audience.
• People who have a lower than high school reading level may have trouble 
with document comprehension as mentioned by a reviewer.
• Low T symptoms are vague. Patients may still readily relate to non-specific 
symptoms like fatigue despite proper education materials.
Recommendations for Future
• As the topic is of current debate and research is being conducted on the subject, 
the handout should be updated accordingly in the future to reflect the latest 
studies.
• The education handout can be updated to use simpler language so that it is 
suitable for people of various educational background.
• Increase provider awareness on the document’s existence to increase document 
usage.
• The topic is of public health importance, but due its specific population focus, the 
project may not be suitable for a community-wide approach. It may be of low 
relevance to some people and would not justify the cost in the process.
• A series of community education workshops based upon students’ community 
health project topics that are public-oriented, and having the public self-select to 
attend, can be beneficial.
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